Registered Tanzania · TMDA

GUMEX-S GEL

Potassium nitrate 5 %w/w,SODIUM MONOFLOUROPHOSPHATE 0.7 %w/w

TAN 26 AD 0495

What it does

Monoflourophosphate is a medication used primarily in eye treatments.

Commonly used for: glaucoma, increased eye pressure

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
TAN 26 AD 0495
Registration date
2026-08-12
Expiry date
2031-08-11
Status
Registered/Compliant
Active ingredient
Potassium nitrate 5 %w/w,SODIUM MONOFLOUROPHOSPHATE 0.7 %w/w
Dosage form
-
Strength
-
Pack size
-
Therapeutic class
-
Applicant / LTR
LIFEMEDYS COMPANY LIMITED
Country of origin
INDIA

Source: Tanzania Medicines and Medical Devices Authority · fetched 2026-08-20 03:00:40 · updated 2026-10-22 03:00:45

Disclaimer: This information is sourced from Tanzania Medicines and Medical Devices Authority (Tanzania). Always consult a qualified healthcare professional before using any medication.

About this medicine

Monoflourophosphate is a medication used primarily in eye treatments.

What it treats

  • glaucoma
  • increased eye pressure

How it works

It helps to reduce pressure in the eyes by enhancing fluid drainage.

Who it's for

This medication is for adults and children with certain eye conditions.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: monoflourophosphate

Monoflourophosphate is an organophosphate compound primarily used as an insecticide and acaricide. It is known for its ability to inhibit the enzyme acetylcholinesterase, leading to an accumulation of acetylcholine in the synaptic cleft. This action can result in increased neural stimulation, which is the basis for its effectiveness in pest control. It is also studied for its potential therapeutic applications in certain neurological disorders due to its effects on neurotransmission.

Indications

  • Insecticide
  • Acaricide
  • Potential therapeutic applications in certain neurological disorders

Dosage

Children: Refer to specific product guidelines and local regulations for dosing information.

Adults: Refer to specific product guidelines and local regulations for dosing information.

Mechanism of action

Monoflourophosphate acts as a reversible inhibitor of acetylcholinesterase. By inhibiting this enzyme, it prevents the breakdown of acetylcholine, a neurotransmitter crucial for proper nerve signal transmission. The resulting increase in acetylcholine levels enhances synaptic transmission, which can lead to overstimulation of the nervous system.

Pharmacodynamics

The pharmacodynamics of monoflourophosphate involve its role in enhancing cholinergic transmission. The inhibition of acetylcholinesterase results in prolonged action of acetylcholine at cholinergic receptors, leading to effects such as muscle contraction and increased glandular secretion. Its efficacy as an insecticide is attributed to this mechanism, causing paralysis and death in pests. However, excessive inhibition can lead to toxicity in humans and other non-target organisms.

Pharmacokinetics

Monoflourophosphate is absorbed through the gastrointestinal tract and can also be absorbed via the skin. It is distributed throughout the body and metabolized primarily in the liver. The elimination half-life varies depending on the route of exposure and the individual's metabolic rate. Renal excretion is a key pathway for the elimination of its metabolites, and the pharmacokinetic profile can be influenced by factors such as age, health status, and potential interactions with other drugs.

Contra-indications

  • Hypersensitivity to monofluorophosphate or any of its components
  • Severe renal impairment

Adverse effects

  • Local irritation
  • Allergic reactions
  • Gastrointestinal disturbances
  • Fluoride toxicity (with excessive use)

Interactions

  • Increased risk of fluoride toxicity when used concurrently with other fluoride supplements
  • Potential interaction with calcium-containing supplements leading to reduced fluoride absorption

Precautions

  • Use with caution in patients with renal impairment
  • Monitor for signs of fluoride toxicity, especially in children
  • Avoid ingestion in children to prevent excessive fluoride exposure

Pregnancy

Monofluorophosphate should be used during pregnancy only if clearly needed. Consult healthcare professionals for guidance regarding use during this period.

Breast-feeding

Caution is advised when using monofluorophosphate while breastfeeding. Consult healthcare professionals for advice related to its use during lactation.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Formulations

  • Topical gel
  • Toothpaste
  • Oral rinses

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.